PATH | VRL
Menu

Immunogenicity of Quadrivalent HPV Vaccine Among Girls 11 to 13 Years of Age Vaccinated Using Alternative Dosing Schedules: Results 29 to 32 Months After Third Dose

This article, published in the Journal of Infectious Diseases, reports on a study to examine whether immune responses from alternative human papillomavirus (HPV) vaccine schedules are noninferior to the standard schedule two years after immunization. The authors found similar antibody concentrations after three doses of HPV vaccine regardless of the dose schedule, providing evidence supporting dosing flexibility.

Author: LaMontagne DS, Thiem VD, Huong VM, Tang Y, Neuzil KM

Published: 2013

» Visit web page (English)

(Located at jid.oxfordjournals.org)

Citation: LaMontagne DS, Thiem VD, Huong VM, Tang Y, Neuzil KM. Immunogenicity of Quadrivalent HPV Vaccine Among Girls 11 to 13 Years of Age Vaccinated Using Alternative Dosing Schedules: Results 29 to 32 Months After Third Dose. Journal of Infectious Diseases. 2013;208(8):1325-1334.

Resource types: Peer-reviewed journal

Diseases/vaccines: Human papillomavirus (HPV)

Topics: Introduction and service delivery, Vaccine safety and performance, Disease/vaccine specific information

Regions: Asia